AC Immune (ACIU) EBT Margin (2015 - 2026)
AC Immune (ACIU) posted quarterly EBT Margin of 1322.7% for Q1 2026, up 59942.0% year-over-year from N/an in Q1 2025, and up 68.89% quarter-over-quarter from 4252.37% in Q4 2025.
Powered by 
Analysis
AC Immune (ACIU) EBT Margin (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported EBT Margin for 10 consecutive years, with 1322.7% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 59942.0% year-over-year to 1322.7%; the TTM figure through Mar 2026 stood at 1787.93% (down 160984.0% YoY), while the FY2025 annual figure was 1971.65%, down 178522.0% from the prior year.
- EBT Margin improved to 1322.7% in Q1 2026 per ACIU's latest filing, from 4252.37% in the prior quarter.
- Across five years, EBT Margin topped out at 21.59% in Q3 2024 and bottomed at 53562.86% in Q4 2022.
- Historically, EBT Margin has averaged 6939.82% across 4 years, with a median of 1655.63% in 2025.
- On a YoY basis, EBT Margin climbed as much as 169052 bps in 2025 and fell as far as 286327 bps in 2025.
- AC Immune's EBT Margin stood at 53562.86% in 2022, then surged by 97 bps to 1389.09% in 2024, then sank by 206 bps to 4252.37% in 2025, then surged by 69 bps to 1322.7% in 2026.
- Business Quant data shows ACIU's EBT Margin at 1322.7% in Q1 2026, 4252.37% in Q4 2025, and 1688.82% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | 12.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.40% |
| Mar 31, 2026 | -1,322.70% |
| Dec 31, 2025 | -4,252.37% |
| Sep 30, 2025 | -1,688.82% |
| Jun 30, 2025 | -1,622.43% |
| Mar 31, 2025 | -1,922.12% |
| Dec 31, 2024 | -1,389.09% |
| Sep 30, 2024 | 21.59% |
| Jun 30, 2024 | -3,312.95% |
| Dec 31, 2022 | -1,874,700.00% |
| Sep 30, 2022 | -343.47% |
| Dec 31, 2020 | -2,065.68% |
| Sep 30, 2020 | -1,691.36% |
| Jun 30, 2020 | -1,453.19% |
| Mar 31, 2020 | -62.61% |
| Dec 31, 2019 | -2,261.16% |
| Sep 30, 2019 | 54.51% |
| Jun 30, 2019 | -1,118.40% |
| Mar 31, 2019 | 84.72% |
| Dec 31, 2018 | 25.36% |